Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Enanta starts phase I trial pan-genotypic cyclophilin inhibitor for HCV

June 21, 2016

Takeda begins phase IIb trial for norovirus vaccine

June 21, 2016

Inovio Pharmaceuticals cleared to begin first phase I trial of Zika vaccine

June 21, 2016

Novira Therapeutics patents anti-HBV compounds

June 21, 2016

MEDI-3902 combined with tobramycin shows promise in an acute pneumonia model

June 20, 2016

The Medicines Co. presents new beta-lactamase inhibitors

June 20, 2016

Celgene joins DNDi's Neglected Tropical Diseases Drug Discovery Booster consortium

June 17, 2016

Phase III trial of omadacycline in ABSSSI meets primary and secondary endpoints

June 17, 2016

Novartis expands partnership with MMV for the development of antimalarial compound KAF-156

June 16, 2016

BARDA awards next option on contract to Atox Bio to support development of AB-103

June 16, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...